Life Satisfaction May Affect Bone Density in Postmenopausal Women

New research shows that women aged 60 – 70 who experience more life satisfaction have a higher bone density and lower rates of osteoporosis than women who are not satisfied with their lives. The 10-year study demonstrates that those women who had the least life satisfaction had bone deterioration of as much as 85%. Hence, researchers are now looking at life satisfaction as not only a key element in reducing osteoporosis, but as an important factor in an overall healthy lifestyle.

One Cup of Blueberries May Reduce Cardiovascular Disease

Researchers from Florida State University recently published evidence demonstrating that one cup of blueberries may reduce blood pressure and arterial stiffness stemming from cardiovascular disease. Daily consumption of blueberries has been found to be particularly effective for postmenopausal women with pre- and stage 1 hypertension. Future studies will examine the effects of varying serving sizes of blueberries over longer periods of time.

Potassium Salts Found in Fruits and Vegetables May Prevent Osteoporosis

New research published in the journal, Osteoporosis International, shows that potassium salts found in many fruits and vegetables play a significant role in improving bone health. However scientists are excited to demonstrate for the first time that potassium salts actually reduce bone resorption, the natural process by which bone is broken down, therefore increasing bone strength. Another exciting detail about potassium salts is that when taken in high amounts, potassium salts significantly decrease the excretion of calcium and acid in urine, allowing the body to preserve more bone mineral.

New Drug May Lead to Personalized Approach to Treating Heart Disease

The American Heart Association has published new research in their journal, Circulation: Cardiovascular Genetics, giving details about how patients with cardiovascular disease and a certain genetic background may benefit from the new drug, dalcetrapib. Initial clinical results show a 39% decrease in heart attacks, stroke, unstable angina, coronary revascularizations, and death from cardiovascular disease. Some patients even showed a reduction in atherosclerosis, or thickened blood vessels that often lead to high blood pressure, stroke, etc. The purpose of the study is to determine if medical professionals researchers can design personalized programs whose aim is to decrease heart disease based on genetic background.